Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2018

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Ciprofloxacin ear drops (Cetraxal®) has been accepted for restricted use in the treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms. The restriction limits use to when off-label or unlicensed ciprofloxacin formulations would otherwise be used.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2018' on Email Share 'SMC Update - April 2018' on Delicious Share 'SMC Update - April 2018' on Digg Share 'SMC Update - April 2018' on Facebook Share 'SMC Update - April 2018' on reddit Share 'SMC Update - April 2018' on StumbleUpon Share 'SMC Update - April 2018' on Twitter

atomic-wealth

No Comments to “SMC Update - April 2018”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer